サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン

Title:

サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン

Document Type and Number:

Japanese Patent JP2010505840

Kind Code:

A

Abstract:

In its many embodiments, the present invention provides a class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases (CDKs), methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:

More Like This:

JP5076103	Hydrogenation method using hydrazine and oxygen oxidation catalyst
WO/2024/051590	SALT TYPE AND CRYSTAL FORM OF BENZAZEPINE FUSED RING COMPOUND AND USE THEREOF
JP2002509150	INDUSTRIAL APPLICABILITY [Title of Invention] A triazolopyridazine derivative as a ligand for GABA receptor.

Inventors:

Guji, Timothy Jay.
Palouch, Camille
Dwyer, Michael Pee.

Application Number:

JP2009531446A

Publication Date:

February 25, 2010

Filing Date:

October 02, 2007

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Schering Corporation

International Classes:

C07D487/04; A61K31/395; A61K31/519; A61K45/00; A61P35/00; A61P35/02; A61P43/00

Domestic Patent References:

JP2009511486A	2009-03-19
JP2009511483A	2009-03-19
JP2009511486A	2009-03-19

Foreign References:

US20040106624A1	2004-06-03
WO2004022561A1	2004-03-18
US20040106624A1	2004-06-03
WO2004022561A1	2004-03-18

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: サイクリン依存性キナーゼインヒビターのピラゾロピリミジン

Next Patent: εＰＫＣのＣ２ドメイン由来のペプチドおよびその利用方法